免疫点和治疗系统性红斑狼的治疗方法
1Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong.
ImmunoTargets and therapy
|June 30, 2025
概括
系统性红斑狼 (SLE) 治疗正在推进,新的疗法针对免疫细胞和免疫通路. 未来的研究重点是个性化医学和组合疗法,以改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性红斑狼 (SLE) 涉及复杂的免疫系统失调,导致自身抗体的产生和组织损伤.
- 细胞碎片的清除受损和异常的免疫细胞功能是SLE的关键病理机制.
- 目前的理解强调了先天性和适应性免疫,细胞因子和补充激活的作用.
研究的目的:
- 审查和总结SLE治疗中新型免疫标的证据.
- 讨论新兴的生物制剂,免疫抑制剂和小分子.
- 探索SLE治疗的未来方向,包括个性化药物和组合方法.
主要方法:
- 对SLE病理生理学和治疗点的当前文献的综述.
- 对新生物制剂,免疫抑制药物和小分子抑制剂的分析.
- 讨论临床试验数据和新兴疗法临床前研究.
主要成果:
- 一些针对B细胞,T细胞,树突细胞和细胞因子的新型药物正在开发或临床使用中.
- 抑制细胞内信号通路和蛋白质降解的小分子正在出现.
- 以生物标志物为指导的患者分层对于优化个性化疗法至关重要.
结论:
- 新型免疫疗法为SLE管理提供了有希望的有针对性的方法.
- 个性化医疗策略和组合疗法对于耐火性或渐进性SLE至关重要.
- 需要进一步的研究来完善治疗选择,最大限度地提高疗效,同时最大限度地减少不良事件.
相关概念视频
01:27Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
01:29Autoimmune Disorders
679
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
679
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
277
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
277
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
239
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
239
01:40Cell-mediated Immune Responses
73.7K
Overview
73.7K